HFA Premium Access

Significant underutilization of angiotensin receptor neprolysin inhibitor (ARNI) and other evidence-based heart failure (HF) therapies in an outpatient clinic setting

Session: Poster Session 3 - Chronic Heart Failure – Treatment

Topic: Pharmacotherapy

Speaker: Doctor N. Singh (Atlanta, US)

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Presentation

About the speaker

Doctor Narendra Singh

Atlanta Heart Specialists, LLC, Atlanta (United States of America)

60 more presentations in this session

Effects of mineralocorticoid ceceptor antagonists (MRA) in heart failure patients after up to 12 months of follow-up.

27 May 2019 08:30 - 18:00

Speaker: Doctor L. Buttigieg (Msida, MT)

Thumbnail

Sacubitril valsartan, a multicentric experience

27 May 2019 08:30 - 18:00

Speaker: Mr F. Cortes (Seville, ES)

Thumbnail

Reduction of NT-proBNP in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction in short-term treatment with empagliflozin on top of existing therapy

27 May 2019 08:30 - 18:00

Speaker: Professor B. Kanazirev (Varna, BG)

Thumbnail

Effects of sacubitril/valsartan on real-world patients with heart failure due to non-ischemic cardiomyopathy

27 May 2019 08:30 - 18:00

Speaker: Doctor C. Hsu (Taipei, TW)

Thumbnail

Effects of ivabradine on patients with depressed left ventricular ejection fraction after cardiac resynchronization therapy

27 May 2019 08:30 - 18:00

Speaker: Doctor C. Hsieh (Taipei, TW)

Thumbnail

Benefits of early administration of ivabradine in stabilized patients hospitalized due to worsening heart failure: insights from the Optimize Heart Failure Care Program

27 May 2019 08:30 - 18:00

Speaker: Doctor L. Mircheva (Varna, BG)

Thumbnail

Series of patients treated with sacubitril-valsartan in a cardiology day clinic: efficacy and safety after 6 months of follow-up

27 May 2019 08:30 - 18:00

Speaker: Doctor C. BELTRAN HERRERA (Madrid, ES)

Thumbnail

Effects of empagliflozin on exercise capacity and LV diastolic function in HFpEF and type-2 diabetes mellitus: rationale and design of prospective intervention study

27 May 2019 08:30 - 18:00

Speaker: Doctor A. Borisov (Moscow, RU)

Thumbnail

Acute Effect of Sacubitril/Valsartan on Depression Score in patients with Acute Decompansed Heart Failure on the First Day of Theraphy:A Prospective Analysis from Our Center Experiences

27 May 2019 08:30 - 18:00

Speaker: Associate Professor T. Kivrak (Elazig, TR)

Thumbnail

Titration process and predictors of achieving target dose of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction attending to an outpatient heart failure clinic.

27 May 2019 08:30 - 18:00

Speaker: Doctor M. Rizzo (Sabadell, ES)

Thumbnail